Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Thyroid Eye Disease – A Summary for Patients
source: The University of Iowa
year: 2020
authors: Chase A Liaboe, Thomas J Clark, Erin M Shriver
summary/abstract:Thyroid eye disease (TED) is an inflammatory disease of the eye and the surrounding tissues. The inflammation is due to an autoimmune reaction – the body’s immune system is attacking tissues within and around the eye socket. TED is sometimes referred to by other names, such as Graves’ ophthalmopathy, Graves’ orbitopathy, thyroid-associated ophthalmopathy, and/or thyroid orbitopathy.
About 90% of TED patients also have Graves’ disease, an autoimmune disorder that causes excess thyroid hormone production (hyperthyroidism). However, 10% of patients with TED have either a normal-functioning or under-functioning thyroid (e.g. Hashimoto’s thyroiditis). While control of systemic thyroid hormone levels is crucial in patients with TED, the ocular disease course and severity does not always correlate with thyroid hormone levels.
Most patients with TED have signs and/or symptoms in both eyes, however the severity can differ between the eyes. Some of the most common manifestations of TED are:
• Swelling in and around the eye socket
• Retraction (tightening) of the eyelids
• Strabismus (the eyes are not in alignment with each other) and diplopia (double vision)
• Dry, irritated, red eyes
read more
Related Content
-
Gerald J. Harris, MDGerald J. Harris is Professor of ophthal...
-
Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye DiseaseContext: Thyroid eye disease (TED), a v...
-
No Need to Suffer From Double Vision With Graves’ Diseasehttps://www.youtube.com/watch?v=cQ7-Yi5t...
-
Thyroid Problems in Childrenhttps://www.youtube.com/watch?v=WbpzAVSu...
-
Clinical Outcomes of Graves’ Ophthalmopathy Treated with Intensity Modulated Radiation TherapyBackground: Radiation for Graves’ oph...
-
National Survey for Those Living With Thyroid Eye Disease (TED)Horizon Therapeutics is conducting a nat...
-
Charles Sydnor, MDCharles Sydnor began his private ophthal...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.